Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG37366

GSE1 Knockout Hela Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Uterus (cervix)

  • Disease:

    Adenocarcinoma

CRISPR/Cas9-edited GSE1 Knockout HeLa Polyclonal Cells provide a heterogeneous loss-of-function model to study the scaffolding subunit of the CoREST complex. Disruption of GSE1 in HeLa cervical adenocarcinoma cells destabilizes interactions with RCOR1, LSD1, HDAC1/2, and REST, impacting histone demethylation and deacetylation at silenced neuronal genes. This polyclonal knockout population is ideal for investigating epigenetic gene silencing, cancer epigenetics, and CoREST complex biology. Key applications include Western blotting, RT-qPCR for derepressed targets like SCN2A, ChIP-qPCR for H3K4me2, RNA-seq, and functional assays for proliferation and migration.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HeLa

    Sex of Donor

    Female

    Age

    31 years

    Gene Name

    GSE1

    Gene Identifier

    NCBI Gene ID 23199

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    MEM (with NEAA)

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

GSE1 Knockout HeLa Polyclonal Cells represent a CRISPR/Cas9-mediated gene-disrupted polyclonal cell population engineered to ablate expression of GSE1, a critical scaffolding subunit of the CoREST transcriptional corepressor complex. This knockout model provides a versatile loss-of-function platform for dissecting GSE1-dependent mechanisms of chromatin remodeling and gene silencing within a widely utilized human cancer cell line. The polyclonal format, generated without single-cell cloning, offers a heterogeneous pool of edited alleles that collectively enable robust functional interrogation while avoiding clonal artifacts.

The host HeLa cell line, derived from human cervical adenocarcinoma, is an immortalized epithelial model extensively employed in molecular and cellular biology. HeLa cells harbor a well-characterized genomic and epigenomic landscape, making them particularly suitable for studies of transcriptional regulation, signal transduction, and oncogenic processes. Their rapid proliferation, ease of manipulation, and established protocols for downstream assays further enhance the utility of this knockout model for high-throughput and mechanistic investigations.

GSE1 functions as an essential scaffold that assembles the CoREST complex by bridging the corepressor RCOR1 (CoREST), the histone demethylase KDM1A (LSD1), and the histone deacetylases HDAC1 and HDAC2. This multiprotein assembly is recruited to chromatin by the RE1-silencing transcription factor REST, directing coordinated demethylation of H3K4me2 and deacetylation of histones at RE1 sites. Consequently, GSE1-mediated repression silences neuronal genes such as SCN2A and SYN1, while also modulating additional REST target networks. Through these interactions, GSE1 integrates upstream regulatory signals from REST into epigenetic changes, positioning it as a central node in transcriptional silencing pathways.

Disruption of GSE1 in HeLa cells is predicted to destabilize the CoREST complex, leading to derepression of REST-targeted genes and altered chromatin states. Given HeLa??s origin from cervical adenocarcinoma and its aberrant epigenetic programming, GSE1 knockout enables dissection of how CoREST-dependent silencing contributes to cancer cell phenotypes including proliferation, migration, and survival. This model allows researchers to investigate context-specific dependencies on the REST/CoREST axis and to assess the functional consequences of GSE1 loss in a malignant epithelial background.

This polyclonal knockout cell model is suited for a range of applications, including CoREST complex functional analysis, epigenetic gene regulation studies, and cancer epigenetics research, as well as for modeling neurodevelopmental disease mechanisms where GSE1 is implicated. Representative assays include Western blotting for GSE1, RCOR1, and LSD1 to confirm knockdown; RT-qPCR to quantify derepression of neuronal targets such as SCN2A; ChIP-qPCR to monitor H3K4me2 enrichment at REST binding sites; transcriptome-wide RNA-seq; immunofluorescence localization; and cell-based proliferation, migration, or invasion assays. For further technical specifications or custom inquiries, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)